financetom
Business
financetom
/
Business
/
What's Going On With NIO Shares Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With NIO Shares Tuesday?
Sep 11, 2024 3:18 AM

Chinese EV manufacturer NIO Inc. ( NIO ) shares are trading lower in the premarket session on Tuesday.

According to Benzinga Pro, NIO stock has lost over 46% in the past year. Investors can gain exposure to the stock via Invesco Golden Dragon China ETF ( PGJ ) and KraneShares Electric Vehicles and Future Mobility Index ETF .

Today, Chinese automotive powerhouse Chery has joined Nio’s charging network, becoming the 13th company to do so, reported CnEV Post. On September 10, Wuhan Nio Energy Co Ltd (NIO Power) and Anhui Chery Green Energy Ecological Technology Co Ltd formalized their partnership through a charging service cooperation agreement.

NIO Power’s charging network is now accessible to brands such as Chery, Exceed, and Jetour, offering a broad range of efficient and convenient charging services, the report read.

Also Read: Tesla’s Ambitious FSD Roadmap, Nio Accelerates With Strong Guidance, Faraday Future Gets Lifeline And More: Biggest EV Stories Of The Week

This partnership adds another company to the list of those collaborating with Nio to share its charging facilities, as they aim to leverage one of China’s largest and most extensive charging networks, the report noted.

NIO’s charging network has consistently been accessible to other EV brands.

As of today, NIO boasts one of the largest public charging networks among Chinese car brands, featuring 2,339 supercharging stations with 10,669 charging piles and 1,638 destination charging stations with 12,613 chargers across China.

Additionally, the company operates 2,510 battery swap stations in the country, 843 of which are situated along highways.

Chery’s partnership with NIO to charge network sharing is the second such announcement this month. On September 5, Dongfeng Motor’s premium electric off-road brand, M-Hero, also announced it would access NIO’s charging network, CnEV Post added.

Price Action: NIO shares are trading lower by 1.80% to $5.47 premarket at last check Tuesday.

Read Next:

Trump Wants To End EV Tax Credits But Yellen Warns of Higher Bills, Lost Jobs, and China’s Gain

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna to Collaborate With OpenAI to Launch New Generation of Medicines
Moderna to Collaborate With OpenAI to Launch New Generation of Medicines
Apr 24, 2024
11:36 AM EDT, 04/24/2024 (MT Newswires) -- Moderna ( MRNA ) and OpenAI said Wednesday they will continue to collaborate to launch a new generation of medicines. The drugmaker and Microsoft ( MSFT )-backed (MSFT) OpenAI started their collaboration in early 2023 with the launch of Moderna's ( MRNA ) own instance of ChatGPT, called mChat. Moderna ( MRNA )...
Caltech resolves lawsuit against HP over Wi-Fi patents
Caltech resolves lawsuit against HP over Wi-Fi patents
Apr 24, 2024
April 24 (Reuters) - The California Institute of Technology has agreed to drop its lawsuit accusing HP Inc ( HPQ ) of infringing patents related to wireless communications, according to a filing in Texas federal court. Caltech and HP told the U.S. District Court for the Western District of Texas on Tuesday that they would dismiss the case with prejudice,...
--McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3
--McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3
Apr 24, 2024
11:30 AM EDT, 04/24/2024 (MT Newswires) -- Price: 530.68, Change: -1.32, Percent Change: -0.25 ...
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
Apr 24, 2024
11:33 AM EDT, 04/24/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Wednesday that the UK's Medicines and Healthcare Products Regulatory Agency has granted marketing authorization for Yorvipath as a parathyroid hormone, or PTH, replacement therapy to treat adults with chronic hypoparathyroidism. The UK regulator also granted orphan drug status to Yorvipath, or palopegteriparatide, providing 10 years of market...
Copyright 2023-2026 - www.financetom.com All Rights Reserved